The purpose of this study is to measure, monitor, and analyze long term effects of SARS-CoV-2. The main purpose is to assess the post-hospitalization outcomes of patients who were diagnosed with SAR-CoV-2 by comparing to patients who were hospitalized with an acute neurological disease.
Study Type
OBSERVATIONAL
Enrollment
71
Radiotracer used during the PET-MR scan of the study to identify signs of disease. Used in studies related to Alzheimer's disease. Only FDA approved for investigational use.
Radiotracer used during the PET-MR scan of the study to identify signs of disease. Used in studies related to Alzheimer's disease. Only FDA approved for investigational use.
Mayo Clinic Florida
Jacksonville, Florida, United States
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Post-Covid Functional Status.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Questionnaire for Verifying stroke-free Status.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Patient Health Questionnaire.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Six-Item Screener.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Modified Rankin Scale.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Collect participants' self reported response from questionnaire: Clinical Dementia Rating.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: National Institutes of Health Stroke Scale.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Neuropsychiatric Inventory Questionnaire.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Epworth Sleepiness Scale.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: National Alzheimer's Coordinating Center Unified Data Set
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Unified Parkinson Disease Rating Scale III.
Time frame: Baseline, 9 months, 12 months, 24 months.
Change in neurological, cognitive, and functional trajectories in participants who are status post hospitalization for COVID-19 and participants receiving intensive care for diagnosis other than COVID-19
Collect participants' self reported response from questionnaire: Montreal Cognitive Assessment
Time frame: Baseline, 9 months, 12 months, 24 months.